Showing results (1941-1950 of 2,473) with videos related to
Sort By:
Pageof 248
Cancer Treatment Reviews|June 1, 2025
Adjuvant therapy after resection of intraductal papillary mucinous neoplasm-derived pancreatic cancer: A systematic review and meta-analysisJoseph R Habib, Asad Saulat Fatimi, Omar Mahmud, et al.Cancer Treatment Reviews|June 1, 2025
Key decision factors in second-line therapy: Expert insights on HR+/HER2-metastatic breast cancer post-CDK4/6 inhibitor progressionRoberto Buonaiuto, Andrea Botticelli, Carmen Criscitiello, et al.Cancer Treatment Reviews|May 11, 2025
Optimal bevacizumab treatment strategy in advanced ovarian cancer: A reviewBradley J Monk, Domenica Lorusso, Keiichi Fujiwara, et al.Cancer Treatment Reviews|January 22, 2026
Personalized cancer vaccines and their integration with standard of care modalitiesTiia Snäkä, Alex Friedlaender, Michele Graciotti, et al.Cancer Treatment Reviews|March 20, 2025
Impact of loss of HER2 positivity following neoadjuvant therapy in HER2-positive breast cancer patients on long-term prognosis: A systematic review and meta-analysisShunsuke Nakatani, Takuya Hayashi, Keiko Yamamoto, et al.Cancer Treatment Reviews|April 16, 2013
Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factorsAnne Polk, Merete Vaage-Nilsen, Kirsten Vistisen, et al.Cancer Treatment Reviews|February 26, 2013
Revisiting ovarian cancer preclinical models: implications for a better management of the diseaseFrancesca Ricci, Massimo Broggini, Giovanna DamiaCancer Treatment Reviews|July 16, 2013
Emerging toxicities in the treatment of non-small cell lung cancer: ocular disordersFrancesco Agustoni, Marco Platania, Milena Vitali, et al.Cancer Treatment Reviews|December 11, 2012
Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care?Nicholas G Zaorsky, Matthew T Studenski, Adam P Dicker, et al.Cancer Treatment Reviews|December 11, 2012
Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignanciesMarcin Okroj, Anders Österborg, Anna M BlomPageof 248